Challenges of treatment of patients with acute coronary syndrome undergoing hemodialysis
Authors:
Company:
1 Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovyy bul’var, 6, Kemerovo, 650002, Russian Federation;
2 Kemerovo Regional Clinical Cardiology Dispensary named after academician L.S. Barbarash, Sosnovyy bul’var, 6, Kemerovo, 650002, Russian Federation
For correspondence: Sign in or register.
Type: Case reports
DOI:
For citation: Tavlueva E.V., Shilov A.A., Barbarash O.L. Challenges of treatment of patients with acute coronary syndrome undergoing hemodialysis. Kreativnaya kardiologiya (Creative Cardiology, Russian journal). 2017; 11 (2): 159—68 (in Russ.). DOI: http://dx.doi.org/10.24022/1997-3187-2017-11-2-159-168
Received / Accepted: May 22, 2017 / May 31, 2017
Keywords: acute coronary syndrome hemodialysis
Abstract
This article presents a case report of the patient with acute coronary syndrome, undergoing hemodialysis for 15 years. Approaches to the problems of the revascularization and medical support in these patients are discussed.
References
-
Sud M., Naimark D.M.J. Cardiovascular disease in chronic kidney disease in 2015. Curr. Op. Nephrol. Hypertens. 2016; 25: 203—7.
-
Barbarash O.L., Zykov M.V., Bykova I.S., Kashtalap V.V., Karetni-kova V.N., Barbarash L.S. Role of renal dysfunction and multifocal atherosclerosis in the assessment of prognosis in patients with myocardial infarction and ST-segment elevation. Kardiologiya (Cardiology, Russian journal). 2013; 9: 26—32 (in Russ.).
-
Migliori M., Cantaluppi V., Scatena A., Panichi V. Antiplatelet agents in hemodialysis. J. Nephrol. 2017; 30 (3): 373—83. https://link.springer.com/ article/10.1007/s40620-016-0367-5 (дата обращения/accessed 08.12.2016).
-
Churchill D.N., Taylor D.W, Cook R.J. Canadian hemodialysis morbidity study. Am. J. Kidney Dis. 1992; 19: 214-34.
-
Webster A.C., Nagler E.V., Morton R.L., Masson P Chronic kidney disease. Lancet. 2016; 389 (10075): 1238-52. http://www.thelancet.com/journals/ lancet/article/PIIS0140-6736(16)32064-5/fulltext (дата обращения/accessed 22.11.2016).
-
Windecker S., Kolh P, Alfonso F., Collet J.P, Cremer J., Falk V. et al. 2014 ASC/EACTS Guidelines on myocardial revascularization. The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association of Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2014; 35: 2541-619.
-
Bangalore S., Guo Y, Samadashvili Z., Blecker S., Xu J., Hannan E.L. Revascularization in patients with multivessel coronary artery disease and chronic kidney diseas. J. Am. Coll. Cardiol. 2015; 66 (11): 1209-20.
-
Shroff G.R., Solid C.A., Herzog C.A. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013; 127: 1861-9.
-
Marui A., Kimura T, Nishiwaki N., Mitsudo, K., 18. Komiya, T, Hanyu, M. et al. For the CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am. J. Cardiol. 2014; 114: 555-61. 19.
-
Roberts J.K., McCullough PA. The Management of acute coronary syndromes in patients with chronic kidney disease. Adv. Chronic Kidney Dis. 2014; 21: 472-9.
-
Weir M.A., Dixon S.N., Fleet J.L., Roberts M.A., Hackam D.G., Oliver M.J. et al. p-Blocker dialyz-ability and mortality in older patients receiving hemodialysis. JASN. 2015; 26: 987-96.
-
Shroff G.R., Herzog C.A. p-Blockers in dialysis 20 patients: a nephrocardiology perspective. J. Am. Soc. Nephrol. 2015; 26 (4): 774-6.
-
Jeong K.H., Cho J.H., Woo J.S., Kim J.B., Kim WS., Lee T.W. et al. Platelet reactivity after receiving clopidogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study. Am. J. Kidney Dis. 2015; 65 (6): 916-24.
-
Vazquez E., Sanchez-Perales C., Ortega S., Vazquez-Sanchez T, Quesada E., Salas D. et al. Bleeding risk of anti-thrombotic treatment in 21 patients on haemodialysis. J. Cardiovasc. Pharmacol. 2017; 69 (4): 192-7.
-
Summaria F., Giannico M.B., Talarico G.P. Patrizi R. Antiplatelet therapy in hemodialysis 22 patients undergoing percutaneous coronary interventions. Nephrourol. Mon. 2015; 7 (4): e28099.
-
Hiremath H., Holden R.M., Fergusson D., Zimmerman D.L. Antiplatelet medications in hemodialysis patients: a systematic review of bleed- 23 ing rates. CJASN. 2009; 4 (8): 1347-55.
-
Moradi H., Streja E., Kashyap M.L., Vaziri N.D., Fonarow G.C., Kalantar-Zadeh K. Elevated high- 24 density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol. Dial. Transplant. 2014; 29 (8): 1554-62.
-
Barylski M., Nikfar S., Mikhailidis D.P, Toth P.P., Salari P, Ray K.K. et al. Lipid and blood pressure meta-analysis collaboration group. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy - a meta-analysis of 11 randomized controlled trials involving 21,295 participants. Pharmacol. Res. 2013; 72: 35-44.
-
Drapkina O.M., Korneeva O.N. Statins in chronic kidney disease. Is there a variety of drugs? Kardiovasku-lyarnaya Terapiya i Profilaktika (Cardiovascular Therapy and Prevention, Russian journal). 2015; 14 (6): 78-82 (in Russ.).
-
Sarafidis PA., Persu A., Agarwal R., Burnier M., de Leeuw P., Ferro C. et al. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol. Dial. Transplant. 2017; 32 (4): 620-40.
-
KDIGO Panel. KDIGO clinical practice guide -line for the management of blood pressure in chronic kidney disease. Kidney Int. Suppl. 2012; 2: 343-87.
-
Perkovic V., Li X., Xie X., Liu Y. Renin-angio-tensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: A Bayesian network meta-analysis of randomized clinical trials. AJKD. 2016; 67: 728-41.
-
Georgianos PI., Agarwal R. Pharmacotherapy of hypertension in chronic dialysis patients. Clin. J. Am. Soc. Nephrol. 2016; 11 (11): 2062-75.
-
Bakris G.L., Burkart J.M., Weinhandl E.D. Intensive hemodialysis, blood pressure, and antihypertensive medication use. Am. J. Kidney Dis. 2016; 68 (5, Suppl. 1): S15-23.